keyword
https://read.qxmd.com/read/38652602/simulated-effects-of-acute-left-ventricular-myocardial-infarction-on-mitral-regurgitation-in-an-ovine-model
#1
JOURNAL ARTICLE
Hao Liu, Michael Sacks, Natalie T Simonian, Joseph Gorman, Robert Gorman
Development of patient specific models of LV-MV interactions in ischemic mitral regurgitation (IMR) are complicated by the substantial variability and complex etiologies, making it difficult to extract underlying mechanisms. We thus developed a detailed ovine LV-MV finite element model based for the normal and acute post-MI states. The ovine LV FEM model was first extended to incorporate a detailed MV leaflet sub-model with a functionally-equivalent CT structure. The resulting complete LV-MV model was first used to simulate the full cardiac cycle in the normal state to establish baseline responses...
April 23, 2024: Journal of Biomechanical Engineering
https://read.qxmd.com/read/38652282/2-methoxyestradiol-ameliorates-doxorubicin-induced-cardiotoxicity-by-regulating-the-expression-of-glut4-and-cpt-1b-in-female-rats
#2
JOURNAL ARTICLE
Mohamed H Sobhy, Ahmed Ismail, Mohammed S Abdel-Hamid, Mohamed Wagih, Marwa Kamel
The clinical usage of doxorubicin (DOX) is hampered due to cardiomyopathy. Studies reveal that estrogen (E2) modulates DOX-induced cardiotoxicity. Yet, the exact mechanism is unclear. The objective of the current study is to evaluate the influence of E2 and more specifically its metabolite 2-methoxyestradiol (2ME) on cardiac remodeling and the reprogramming of cardiac metabolism in rats subjected to DOX cardiotoxicity. Seventy-two female rats were divided into groups. Cardiotoxicity was induced by administering DOX (2...
April 23, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38652263/treatment-of-transthyretin-cardiac-amyloidosis
#3
JOURNAL ARTICLE
Dimitrios Bampatsias, Abdirahman Wardhere, Mathew S Maurer
PURPOSE OF REVIEW: Tafamidis is currently the only approved disease-modifying treatment for ATTR-CM. However, there have been important developments in the treatment of ATTR-CM, as the results of two phase 3 trials were published and several other trials are in their final stages. In this review, we summarize current and future therapies for ATTR-CM. RECENT FINDINGS: Recently, acoramidis, a TTR stabilizer has been proven to be effective in reducing mortality and morbidity compared to placebo in the ATTRibute-CM trial...
April 22, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652213/severe-st-segment-elevation-and-av-block-during-pulsed-field-ablation-due-to-vasospastic-angina-a-novel-observation
#4
JOURNAL ARTICLE
David Schaack, Karin Plank, Stefano Bordignon, Lukas Urbanek, Shota Tohoku, Jun Hirokami, Boris Schmidt, Julian Kyoung-Ryul Chun
Catheter ablation of atrial fibrillation using non-thermal electroporation represents a promising ablation modality due to its believed superior safety profile. Still, if electroporation is delivered in proximity to a coronary artery, vasospasms can occur. We report the first case of severe right coronary artery vasospasm resulting in ST-segment elevation and AV block despite a remote distance from the ablation site to the right coronary artery, indicating a different mechanism. In this case, electroporation most likely triggered a previously unknown Prinzmetal vasospastic angina in the patient, resulting in the coronary vasospasm...
April 23, 2024: Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing
https://read.qxmd.com/read/38652080/cannabidiol-potentiates-hyperpolarization-activated-cyclic-nucleotide-gated-hcn4-channels
#5
JOURNAL ARTICLE
Dana A Page, Peter C Ruben
Cannabidiol (CBD), the main non-psychotropic phytocannabinoid produced by the Cannabis sativa plant, blocks a variety of cardiac ion channels. We aimed to identify whether CBD regulated the cardiac pacemaker channel or the hyperpolarization-activated cyclic nucleotide-gated channel (HCN4). HCN4 channels are important for the generation of the action potential in the sinoatrial node of the heart and increased heart rate in response to β-adrenergic stimulation. HCN4 channels were expressed in HEK 293T cells, and the effect of CBD application was examined using a whole-cell patch clamp...
June 3, 2024: Journal of General Physiology
https://read.qxmd.com/read/38651583/what-the-pediatric-nurse-needs-to-know-about-the-impella-cardiac-assist-device
#6
JOURNAL ARTICLE
Giorgia Borrelli, Ilaria Nittolo, Chiara Bochicchio, Laura Trainelli, Valerio Confalone, Tiziana Satta, Federica Cancani, Richard Kirk, Antonio Amodeo, Matteo Di Nardo
Background: Cardiogenic shock in children still carries a high mortality risk despite advances in medical therapy. The use of temporary mechanical circulatory supports is an accepted strategy to bridge patients with acute heart failure to recovery, decision, transplantation or destination therapy. These devices are however limited in children and extracorporeal membrane oxygenation (ECMO) remains the most commonly used device. Veno-arterial ECMO may provide adequate oxygen delivery, but it does not significantly unload the left ventricle, and this may prevent recovery...
April 2024: Perfusion
https://read.qxmd.com/read/38651580/the-physiology-of-venoarterial-extracorporeal-membrane-oxygenation-a-comprehensive-clinical-perspective
#7
JOURNAL ARTICLE
Libera Fresiello, Jeannine A J Hermens, Lara Pladet, Christiaan L Meuwese, Dirk W Donker
Venoarterial extracorporeal membrane oxygenation (VA ECMO) has become a standard of care for severe cardiogenic shock, refractory cardiac arrest and related impending multiorgan failure. The widespread clinical use of this complex temporary circulatory support modality is still contrasted by a lack of formal scientific evidence in the current literature. This might at least in part be attributable to VA ECMO related complications, which may significantly impact on clinical outcome. In order to limit adverse effects of VA ECMO as much as possible an indepth understanding of the complex physiology during extracorporeally supported cardiogenic shock states is critically important...
April 2024: Perfusion
https://read.qxmd.com/read/38651575/left-ventricular-unloading-in-patients-supported-with-veno-arterial-extra-corporeal-membrane-oxygenation-an-international-euroelso-survey
#8
JOURNAL ARTICLE
Saad M Ezad, Matthew Ryan, Nicholas Barrett, Luigi Camporota, Justyna Swol, Marta V Antonini, Dirk W Donker, Federico Pappalardo, Navin K Kapur, Louise Rose, Divaka Perera
INTRODUCTION: Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) improves end-organ perfusion in cardiogenic shock but may increase afterload, which can limit cardiac recovery. Left ventricular (LV) unloading strategies may aid cardiac recovery and prevent complications of increased afterload. However, there is no consensus on when and which unloading strategy should be used. METHODS: An online survey was distributed worldwide via the EuroELSO newsletter mailing list to describe contemporary international practice and evaluate heterogeneity in strategies for LV unloading...
April 2024: Perfusion
https://read.qxmd.com/read/38651573/mechanical-ventilation-during-extracorporeal-membrane-oxygenation-support-new-trends-and-continuing-challenges
#9
JOURNAL ARTICLE
Konstanty Szuldrzynski, Mariusz Kowalewski, Justyna Swol
BACKGROUND: The impact of mechanical ventilation on the survival of patients supported with veno-venous extracorporeal membrane oxygenation (V-V ECMO) due to severe acute respiratory distress syndrome (ARDS) remains still a focus of research. METHODS: Recent guidelines, randomized trials, and registry data underscore the importance of lung-protective ventilation during respiratory and cardiac support on ECMO. RESULTS: This approach includes decreasing mechanical power delivery by reducing tidal volume and driving pressure as much as possible, using low or very low respiratory rate, and a personalized approach to positive-end expiratory pressure (PEEP) setting...
April 2024: Perfusion
https://read.qxmd.com/read/38651541/hemodynamics-of-low-pressure-cardiac-tamponade-an-illustrative-case-report
#10
Rasmey Thach, Robert Blank, Charles Lin
A 55-year-old male with acute pericarditis presented with low-pressure cardiac tamponade (LPCT) unresponsive to volume infusion. Subsequent pericardiocentesis resulted in hemodynamic improvement and unmasking of pericardial constriction. This case provides illustrative hemodynamic tracings of LPCT. Additionally, the presence of concurrent pericardial constriction that may indicate a plausible underlying mechanism for the blunted responsiveness to fluid expansion in LPCT. The underlying physiologic processes and the associated hemodynamic tracings are discussed...
April 23, 2024: Catheterization and Cardiovascular Interventions
https://read.qxmd.com/read/38650919/the-mechanics-of-congenital-heart-disease-from-a-morphological-trait-to-the-functional-echocardiographic-evaluation
#11
REVIEW
Martina Avesani, Jolanda Sabatino, Nunzia Borrelli, Irene Cattapan, Isabella Leo, Giulia Pelaia, Sara Moscatelli, Francesco Bianco, PierPaolo Bassareo, Francesco Martino, Benedetta Leonardi, Lilia Oreto, Paolo Guccione, Giovanni Di Salvo
Advances in pediatric cardiac surgery have resulted in a recent growing epidemic of children and young adults with congenital heart diseases (CHDs). In these patients, congenital defects themselves, surgical operations and remaining lesions may alter cardiac anatomy and impact the mechanical performance of both ventricles. Cardiac function significantly influences outcomes in CHDs, necessitating regular patient follow-up to detect clinical changes and relevant risk factors. Echocardiography remains the primary imaging method for CHDs, but clinicians must understand patients' unique anatomies as different CHDs exhibit distinct anatomical characteristics affecting cardiac mechanics...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38650918/research-progress-on-the-improvement-of-cardiovascular-diseases-through-the-autonomic-nervous-system-regulation-of-the-nlrp3-inflammasome-pathway
#12
REVIEW
Yuchi Hu, Songyuan Dai, Lulu Zhao, Ling Zhao
Cardiovascular disease stands as a leading global cause of mortality. Nucleotide-binding Oligomerization Domain-like Receptor Protein 3 (NLRP3) inflammasome is widely acknowledged as pivotal factor in specific cardiovascular disease progression, such as myocardial infarction, heart failure. Recent investigations underscore a close interconnection between autonomic nervous system (ANS) dysfunction and cardiac inflammation. It has been substantiated that sympathetic nervous system activation and vagus nerve stimulation (VNS) assumes critical roles withinNLRP3 inflammasome pathway regulation, thereby contributing to the amelioration of cardiac injury and enhancement of prognosis in heart diseases...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38650769/a-comprehensive-review-on-unveiling-the-journey-of-digoxin-past-present-and-future-perspectives
#13
REVIEW
Rahul Khandelwal, Jayant D Vagha, Revat J Meshram, Ankita Patel
Digoxin, a cardiac glycoside derived from the foxglove plant ( Digitalis spp.), has been utilized for centuries in managing various cardiac conditions due to its ability to increase myocardial contractility and regulate heart rate. This comprehensive review explores the historical context, pharmacological properties, clinical applications, efficacy, safety profile, challenges, and future perspectives of digoxin. Tracing its journey from traditional medicine to modern cardiovascular therapeutics, we delve into its mechanism of action, therapeutic indications, and clinical guidelines...
March 2024: Curēus
https://read.qxmd.com/read/38649588/therapeutic-potential-of-conduction-system-pacing-as-a-method-for-improving-cardiac-output-during-ventricular-tachycardia
#14
JOURNAL ARTICLE
Daniel Keene, Alejandra A Miyazawa, Ahran D Arnold, Akriti Naraen, Nandita Kaza, Jagdeep S Mohal, David C Lefroy, Phang Boon Lim, Fu Siong Ng, Michael Koa-Wing, Norman A Qureshi, Nick W F Linton, Ian Wright, Nicholas S Peters, Prapa Kanagaratnam, Matthew J Shun-Shin, Darrel P Francis, Zachary I Whinnett
BACKGROUND: Ventricular tachycardia (VT) reduces cardiac output through high heart rates, loss of atrioventricular synchrony, and loss of ventricular synchrony. We studied the contribution of each mechanism and explored the potential therapeutic utility of His bundle pacing to improve cardiac output during VT. METHODS: Study 1 aimed to improve the understanding of mechanisms of harm during VT (using pacing simulated VT). In 23 patients with left ventricular impairment, we recorded continuous ECG and beat-by-beat blood pressure measurements...
April 22, 2024: Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing
https://read.qxmd.com/read/38649132/inhibition-of-mir-146b-5p-alleviates-isoprenaline-induced-cardiac-hypertrophy-via-regulating-dfcp1
#15
JOURNAL ARTICLE
Siling Liu, Linjie Su, Jie Li, Yuexin Zhang, Xiaopei Hu, Pengcheng Wang, Peiqing Liu, Jiantao Ye
Pathological cardiac hypertrophy often precedes heart failure due to various stimuli, yet effective clinical interventions remain limited. Recently, microRNAs (miRNAs) have been identified as critical regulators of cardiovascular development. In this study, we investigated the role of miR-146b-5p and its underlying mechanisms of action in cardiac hypertrophy. Isoprenaline (ISO) treatment induced significant hypertrophy and markedly enhanced the expression of miR-146b-5p in cultured neonatal rat cardiomyocytes and hearts of C57BL/6 mice...
April 20, 2024: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/38649052/perfluoroalkyl-sulfonate-induces-cardiomyocyte-apoptosis-via-endoplasmic-reticulum-stress-activation-and-autophagy-flux-inhibition
#16
JOURNAL ARTICLE
Yuanhao Wang, Da Yin, Xin Sun, Wei Zhang, Huan Ma, Jingnan Huang, Chuanbin Yang, Jigang Wang, Qingshan Geng
Perfluoroalkyl sulfonate (PFOS) is a commonly used chemical compound that often found in materials such as waterproofing agents, food packaging, and fire retardants. Known for its stability and persistence in the environment, PFOS can enter the human body through various pathways, including water and the food chain, raising concerns about its potential harm to human health. Previous studies have suggested a cardiac toxicity of PFOS, but the specific cellular mechanisms remained unclear. Here, by using AC16 cardiomyocyte as a model to investigate the molecular mechanisms potential the cardiac toxicity of PFOS...
April 20, 2024: Science of the Total Environment
https://read.qxmd.com/read/38648963/mybpc3-c-772g%C3%A2-%C3%A2-a-mutation-results-in-haploinsufficiency-and-altered-myosin-cycling-kinetics-in-a-patient-induced-stem-cell-derived-cardiomyocyte-model-of-hypertrophic-cardiomyopathy
#17
JOURNAL ARTICLE
Steczina Sonette, Saffie Mohran, Logan R J Bailey, Timothy S McMillen, Kristina B Kooiker, Neil B Wood, Jennifer Davis, Michael J Previs, Iacopo Olivotto, Josè Manuel Pioner, Michael A Geeves, Corrado Poggesi, Michael Regnier
Approximately 40% of hypertrophic cardiomyopathy mutations are linked to the sarcomere protein cardiac myosin binding protein-C (cMyBP-C). These mutations are either classified as missense mutations or truncation mutations. One mutation whose nature has been inconsistently reported in the literature is the MYBPC3-c.772G > A mutation. Using patient-derived human induced pluripotent stem cells differentiated to cardiomyocytes (hiPSC-CMs), we have performed a mechanistic study of the structure-function relationship for this MYBPC3-c...
April 20, 2024: Journal of Molecular and Cellular Cardiology
https://read.qxmd.com/read/38648903/hippo-pathway-activated-by-circulating-reactive-oxygen-species-mediates-cardiac-diastolic-dysfunction-after-acute-kidney-injury
#18
JOURNAL ARTICLE
Xiao Han, Quan Hong, Fei Peng, Yan Zhang, Lingling Wu, Xu Wang, Ying Zheng, Xiangmei Chen
Acute kidney injury (AKI) can cause distal cardiac dysfunction; however, the underlying mechanism is unknown. Oxidative stress is proved prominent in AKI-induced cardiac dysfunction, and a possible bridge role of oxidative-stress products in cardio-renal interaction has been reported. Therefore, this study aimed to investigate the critical role of circulating reactive oxygen species (ROS) in mediating cardiac dysfunction after bilateral renal ischemia-reperfusion injury (IRI). We observed the diastolic dysfunction in the mice following renal IRI, accompanied by reduced ATP levels, oxidative stress, and branched-chain amino acids (BCAA) accumulation in the heart...
April 20, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38648799/cardiomyocyte-adaptation-to-exercise-k-channels-contractility-and-ischemic-injury
#19
JOURNAL ARTICLE
Robert H Fitts, Xinrui Wang, Wai-Meng Kwok, Amadou K S Camara
Cardiovascular disease is a leading cause of morbidity and mortality, and exercise-training (TRN) is known to reduce risk factors and protect the heart from ischemia and reperfusion injury. Though the cardioprotective effects of exercise are well-documented, underlying mechanisms are not well understood. This review highlights recent findings and focuses on cardiac factors with emphasis on K+ channel control of the action potential duration (APD), β-adrenergic and adenosine regulation of cardiomyocyte function, and mitochondrial Ca2+ regulation...
April 22, 2024: International Journal of Sports Medicine
https://read.qxmd.com/read/38648737/intrathecal-anesthesia-prevents-ventricular-arrhythmias-in-rats-with-myocardial-ischemia-reperfusion
#20
JOURNAL ARTICLE
Huabin Zhang, Yue Wang, Yong Wu, Zhongxu Luo, Ming Zhong, Zongyuan Hong, Deguo Wang
INTRODUCTION: Ventricular arrhythmia is commonly provoked by acute cardiac ischemia through sympathetic exaggeration and is often resistant to antiarrhythmic therapies. Thoracic epidural anesthesia has been reported to terminate fatal ventricular arrhythmia; however, its underlying mechanism is unknown. METHODS: Rats were randomly divided into four groups: sham, sham plus bupivacaine, ischemia/reperfusion (IR), and IR plus bupivacaine groups. Bupivacaine (1 mg/mL, 0...
April 22, 2024: Pharmacology
keyword
keyword
118480
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.